PUBLICATIONS · 24836273
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2014 Jun
- First author
- Sartor O
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2014 Jun;15(7):675-6. doi: 10.1016/S1470-2045(14)70217-7.
- note
- Source null
- related pmid
- 24836275
- relationship
- Comment in
- citation
- J Urol. 2015 Mar;193(3):847-8. doi: 10.1016/j.juro.2014.12.077.
- note
- Source null
- related pmid
- 25765385
- relationship
- Comment in
Authors and identifiers
- name
- Sartor O
- type
- Author
- name
- Coleman R
- type
- Author
- name
- Nilsson S
- type
- Author
- name
- Heinrich D
- type
- Author
- name
- Helle SI
- type
- Author
- name
- O'Sullivan JM
- type
- Author
- name
- Fosså SD
- type
- Author
- name
- Chodacki A
- type
- Author
- name
- Wiechno P
- type
- Author
- name
- Logue J
- type
- Author
- name
- Widmark A
- type
- Author
- name
- Johannessen DC
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Sartor O
- type
- Author
- name
- Coleman R
- type
- Author
- name
- Nilsson S
- type
- Author
- name
- Heinrich D
- type
- Author
- name
- Helle SI
- type
- Author
- name
- O'Sullivan JM
- type
- Author
- name
- Fosså SD
- type
- Author
- name
- Chodacki A
- type
- Author
- name
- Wiechno P
- type
- Author
- name
- Logue J
- type
- Author
- name
- Widmark A
- type
- Author
- name
- Johannessen DC
- type
- Author
- bibliography ids
- nci-bib-48ca80aa565a2bb3cd1f2122
- book metadata
- content sha256
- 8ebbda1f64f341509d762106a54595c32dd5b67cbb36ffbdf1aabf50bf0bd06b
- document type
- citation
- dois
- 10.1016/S1470-2045(14)70183-4
- electronic publication date
- display
- 2014 May 13
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24836273
- immutable id
- pubmed:24836273@8ebbda1f64f341509d762106a54595c32dd5b67cbb36ffbdf1aabf50bf0bd06b
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 7
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 738-46
- volume
- 15
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2014 Jun;15(7):675-6. doi: 10.1016/S1470-2045(14)70217-7.
- note
- Source null
- related pmid
- 24836275
- relationship
- Comment in
- citation
- J Urol. 2015 Mar;193(3):847-8. doi: 10.1016/j.juro.2014.12.077.
- note
- Source null
- related pmid
- 25765385
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 24836273
- provenance
- batch id
- 063b6c38419f18d4021f
- provider
- NCBI PubMed ESummary
- record sha256
- ed96dd3defd8d1323efe9c2cf5d4de717022988b53ae2334c9b7502b4edd037b
- response sha256
- 5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
- retrieved at
- 2026-09-09T23:47:02.607425+00:00
- publication date
- display
- 2014 Jun
- precision
- month
- year
- 2014
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Preserved source evidence · Not medical advice
Triangle